Myomo, Inc.
Healthcare sector | Medical Devices industry
Metrics for MYO
| Price | $0.79 |
|---|---|
| Shares Outstanding | 38.51M |
| All-Time Low | $0.37 |
| 52-Week Low | $0.71 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.01 |
| Net Tangible Assets / Share | $0.25 |
| Avg CA Burn (Quarterly %) | 20.08% (as of 4-15-2026) |
Earning Metrics
| Max Earning Power / Share | $-0.57 |
|---|---|
| Adjusted Earning Power |
$-0.94
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-3,813,938 / 0.105) / 38,511,715) = -0.9432 |
| Non-Cash Charges to Market Cap |
2.19%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 4-15-2026 |
| Consecutive Years Paid | No | 4-15-2026 |
| Pays Dividend | No | 4-15-2026 |
| Last Dividend Date | 1-30-20 | |
| Income indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 4-15-2026 |
| EBITDA Positive | No | 4-15-2026 |
| Net Income Positive | No | 4-15-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 2 quarterly.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $0.26 | 9.8M ($9,812,603) | 38.5M (38,471,356) |
| 2025-09-30 | Quarterly | $0.38 | 14.6M ($14,625,583) | 38.4M (38,433,260) |
Revenue History (Annual)
Revenue from income statements.
| Report Date | Revenue |
|---|---|
| No annual revenue history available yet | |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-17 | 38,511,715 | +76,191 |
Short Interest Changes
Latest short-interest change: 3,786,607 shares (10.25% of float) | Days to cover: 10.26
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-04-13 | 3,786,607 shares | -1,102,408 | -22.55% |
| 2026-03-24 | 4,889,015 shares | +300,522 | +6.55% |
| 2026-03-11 | 4,588,493 shares | -177,991 | -3.73% |
| 2026-02-26 | 4,766,484 shares | +46,447 | +0.98% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.